211 related articles for article (PubMed ID: 28429253)
1. Modified Metformin as a More Potent Anticancer Drug: Mitochondrial Inhibition, Redox Signaling, Antiproliferative Effects and Future EPR Studies.
Kalyanaraman B; Cheng G; Hardy M; Ouari O; Sikora A; Zielonka J; Dwinell MB
Cell Biochem Biophys; 2017 Dec; 75(3-4):311-317. PubMed ID: 28429253
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-targeted metformins: anti-tumour and redox signalling mechanisms.
Kalyanaraman B; Cheng G; Hardy M; Ouari O; Sikora A; Zielonka J; Dwinell M
Interface Focus; 2017 Apr; 7(2):20160109. PubMed ID: 28382202
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Targeting of Metformin Enhances Its Activity against Pancreatic Cancer.
Boukalova S; Stursa J; Werner L; Ezrova Z; Cerny J; Bezawork-Geleta A; Pecinova A; Dong L; Drahota Z; Neuzil J
Mol Cancer Ther; 2016 Dec; 15(12):2875-2886. PubMed ID: 27765848
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells.
Cheng G; Zielonka J; Ouari O; Lopez M; McAllister D; Boyle K; Barrios CS; Weber JJ; Johnson BD; Hardy M; Dwinell MB; Kalyanaraman B
Cancer Res; 2016 Jul; 76(13):3904-15. PubMed ID: 27216187
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
Cheng G; Zielonka J; McAllister D; Hardy M; Ouari O; Joseph J; Dwinell MB; Kalyanaraman B
Cancer Lett; 2015 Aug; 365(1):96-106. PubMed ID: 26004344
[TBL] [Abstract][Full Text] [Related]
6. EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells.
d'Hose D; Mathieu B; Mignion L; Hardy M; Ouari O; Jordan BF; Sonveaux P; Gallez B
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144606
[TBL] [Abstract][Full Text] [Related]
7. Metformin selectively targets redox control of complex I energy transduction.
Cameron AR; Logie L; Patel K; Erhardt S; Bacon S; Middleton P; Harthill J; Forteath C; Coats JT; Kerr C; Curry H; Stewart D; Sakamoto K; Repiščák P; Paterson MJ; Hassinen I; McDougall G; Rena G
Redox Biol; 2018 Apr; 14():187-197. PubMed ID: 28942196
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation.
Boyle KA; Van Wickle J; Hill RB; Marchese A; Kalyanaraman B; Dwinell MB
J Biol Chem; 2018 Sep; 293(38):14891-14904. PubMed ID: 30087121
[TBL] [Abstract][Full Text] [Related]
9. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
[TBL] [Abstract][Full Text] [Related]
10. Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies.
Kalyanaraman B; Cheng G; Hardy M; Ouari O; Bennett B; Zielonka J
Redox Biol; 2018 May; 15():347-362. PubMed ID: 29306792
[TBL] [Abstract][Full Text] [Related]
11. A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds.
Kalyanaraman B; Cheng G; Hardy M; Ouari O; Lopez M; Joseph J; Zielonka J; Dwinell MB
Redox Biol; 2018 Apr; 14():316-327. PubMed ID: 29017115
[TBL] [Abstract][Full Text] [Related]
12. Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD).
Sharma P; Kumar S
Cell Oncol (Dordr); 2018 Dec; 41(6):637-650. PubMed ID: 30088260
[TBL] [Abstract][Full Text] [Related]
13. Low-Temperature EPR Spectroscopy as a Probe-Free Technique for Monitoring Oxidants Formed in Tumor Cells and Tissues: Implications in Drug Resistance and OXPHOS-Targeted Therapies.
Kalyanaraman B; Cheng G; Zielonka J; Bennett B
Cell Biochem Biophys; 2019 Mar; 77(1):89-98. PubMed ID: 30259334
[TBL] [Abstract][Full Text] [Related]
14. Metformin suppresses the invasive ability of pancreatic cancer cells by blocking autocrine TGF‑β1 signaling.
Duan W; Qian W; Zhou C; Cao J; Qin T; Xiao Y; Cheng L; Li J; Chen K; Li X; Ma J; Ma Q
Oncol Rep; 2018 Sep; 40(3):1495-1502. PubMed ID: 29956804
[TBL] [Abstract][Full Text] [Related]
15. A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers.
Millard M; Gallagher JD; Olenyuk BZ; Neamati N
J Med Chem; 2013 Nov; 56(22):9170-9. PubMed ID: 24147900
[TBL] [Abstract][Full Text] [Related]
16. Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis.
Isakovic A; Harhaji L; Stevanovic D; Markovic Z; Sumarac-Dumanovic M; Starcevic V; Micic D; Trajkovic V
Cell Mol Life Sci; 2007 May; 64(10):1290-302. PubMed ID: 17447005
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial redox cycling of mitoquinone leads to superoxide production and cellular apoptosis.
Doughan AK; Dikalov SI
Antioxid Redox Signal; 2007 Nov; 9(11):1825-36. PubMed ID: 17854275
[TBL] [Abstract][Full Text] [Related]
18. TPP-related mitochondrial targeting copper (II) complex induces p53-dependent apoptosis in hepatoma cells through ROS-mediated activation of Drp1.
Shao J; Li M; Guo Z; Jin C; Zhang F; Ou C; Xie Y; Tan S; Wang Z; Zheng S; Wang X
Cell Commun Signal; 2019 Nov; 17(1):149. PubMed ID: 31744518
[TBL] [Abstract][Full Text] [Related]
19. Water-Soluble Gold(III)-Metformin Complex Alters Mitochondrial Bioenergetics in Breast Cancer Cells.
Hyun Kim J; Ofori S; Mertens RT; Parkin S; Awuah SG
ChemMedChem; 2021 Oct; 16(20):3222-3230. PubMed ID: 34159760
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial targets of metformin-Are they physiologically relevant?
Pecinová A; Brázdová A; Drahota Z; Houštěk J; Mráček T
Biofactors; 2019 Sep; 45(5):703-711. PubMed ID: 31343786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
